Ocular Therapeutix, Inc.
OCUL
$11.04
$0.282.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -37.43% | -43.21% | -56.65% | -67.19% | -139.68% |
| Total Depreciation and Amortization | 14.18% | 6.17% | 5.18% | 12.49% | 26.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.90% | -36.28% | -44.25% | -23.06% | 337.19% |
| Change in Net Operating Assets | 175.37% | 160.48% | 156.13% | 146.37% | -38.04% |
| Cash from Operations | -52.13% | -61.48% | -97.92% | -72.86% | -91.75% |
| Capital Expenditure | -832.45% | -506.67% | -102.27% | -0.10% | 78.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -822.36% | -498.25% | -94.69% | -0.10% | 78.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 69.14% | -73.18% | -74.40% | -96.57% | 179.88% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 69.14% | -73.18% | -77.11% | -96.93% | 95.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 75.87% | -126.05% | -117.45% | -133.02% | 109.77% |